Trace-Ability, Inc.
6162 Bristol Parkway, Suite 200
Culver City
CA
United States
1 article about Trace-Ability, Inc.
-
FDA Allows the First Use of Tracer-QC at Massachusetts General Hospital
4/17/2018
Trace-Ability, Inc. announced today that the U.S. Food and Drug Administration (FDA) has allowed the first use of its product, Tracer-QC, for release testing of an imaging agent used in Positron Emission Tomography (PET) - [N-13]Ammonia for injection.